Home LiteratureArticle Details
PMID: 11875107 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer.

Molecular endocrinology (Baltimore, Md.) ·Vol. 16 ·No. 3 ·2002-03-00 ·Pages 487-96

Weatherman RV, Chang CY, Clegg NJ, Carroll DC, Day RN, Baxter JD, McDonnell DP, Scanlan TS, Schaufele F

Abstract

Some aspects of ligand-regulated transcription activation by the estrogen receptor (ER) are associated with the estrogen-dependent formation of a hydrophobic cleft on the receptor surface. At least in vitro, this cleft is required for direct interaction of ER with an alpha helix, containing variants of the sequence LXXLL, found in many coactivators. In cells, it is unknown whether ER interactions with the different LXXLL-containing helices are uniformly similar or whether they vary with LXXLL sequence or activating ligand. Using fluorescence resonance energy transfer (FRET), we confirm in the physiological environment a direct interaction between the estradiol (E2)-bound ER and LXXLL peptides expressed in living cells as fusions with spectral variants of the green fluorescent protein. This interaction was blocked by a single amino acid mutation in the hydrophobic cleft. No FRET was detected when cells were incubated with the antiestrogenic ligands tamoxifen and ICI 182,780. E2, diethylstilbestrol, ethyl indenestrol A, and 6,4'-dihydroxyflavone all promoted FRET and activated ER-dependent transcription. Measurement of the level of FRET of ER with different LXXLL-containing peptides suggested that the orientations or affinities of the LXXLL interactions with the hydrophobic cleft were globally similar but slightly different for some activating ligands.

MeSH Terms
Cell Line Diethylstilbestrol/metabolism Energy Transfer Estradiol/analogs & derivatives,metabolism,pharmacology Estrogen Receptor alpha Fulvestrant Green Fluorescent Proteins Ligands Luminescent Proteins/genetics Peptides/chemistry,genetics,metabolism Protein Structure, Secondary Receptors, Estrogen/genetics,metabolism Recombinant Fusion Proteins/metabolism Response Elements Selective Estrogen Receptor Modulators/metabolism,pharmacology Spectrometry, Fluorescence Tamoxifen/metabolism,pharmacology Transcription, Genetic
Chemicals
Estrogen Receptor alpha Ligands Luminescent Proteins Peptides Receptors, Estrogen Recombinant Fusion Proteins Selective Estrogen Receptor Modulators red fluorescent protein Tamoxifen Green Fluorescent Proteins Fulvestrant Estradiol Diethylstilbestrol
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Weatherman R V
Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco, California 94143-0446, USA.
Chang C-Y
Clegg N J
Carroll D C
Day R N
Baxter J D
McDonnell D P
Scanlan T S
Schaufele F
Article Info
Journal
Molecular endocrinology (Baltimore, Md.)
Abbr.
Mol Endocrinol
ISSN
0888-8809
Published
2002-03-00
Pages
487-96
Language
English
Region
United States
NLM ID
8801431
Subset
IM
Grants
NIDDK NIH HHS · DK-48807 · United States
NIDDK NIH HHS · DK-54345 · United States
NIDDK NIH HHS · DK-57574 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com